Ingenious Targeting Laboratory Inc.
Holbrook, NY
- UEI
- KLFLHV967JW4
- CAGE
- 3DC70
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 761 Coates Ave #80, Holbrook, NY 11741, USA
- Website
- genetargeting.com
- Founded
- 1998
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Niddk: supplies - this firm fixed price purchase order is awarded for custom conditional knockin mouse to ingenious… | Office of Logisitics and Acquisition Operations | $21,889 | |
| FY26 UDO initiative - custom conditional gpnmb cdna cassette knockin mouse model | National Institute on Drug Abuse | $25,098 | |
| Live mice | Veterans Integrated Service Network 22 | $18,388 | |
| Knockin mouse ES cell line | National Institute of Child Health and Human Development | $13,838 | |
| Custom reporter cdna replacement knockin mouse - research animal | National Institute on Aging | $22,298 |
About Ingenious Targeting Laboratory Inc.
Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned small disadvantaged business located in Holbrook, New York, develops custom genetically modified mice and related research animal models for federal biomedical research agencies as a prime contractor. The company operates exclusively as a prime vendor (100% of recent awards) and competes under full-and-open and small-business set-aside designations; it does not subcontract.
Ingenious Targeting's capability portfolio centers on custom gene targeting, conditional knockin and knockout mouse production, cDNA cassette engineering, and humanized mouse model development for biomedical research. Representative prime work includes a $21,889 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases in February 2026 for custom conditional knockin mouse production (Gene ID: ENSEMBL:ENSMUSG00000000394), a $25,098 purchase order from the National Institute on Aging in August 2024 for a custom conditional GPNMB cDNA cassette knockin mouse model to support macrophage research, and a $18,388 purchase order from the Veterans Health Administration's Veterans Integrated Service Network 22 in November 2023 for live mice to support biomedical research. The company maintains IACUC approval and AAALAC accreditation, meeting Public Health Service Policy requirements for humane care and use of laboratory animals.
Customer concentration is heavily skewed to NIH institutes. The top five customer agencies account for 57% of recent awards by count and 60% of combined potential value, with the National Institute of Diabetes and Digestive and Kidney Diseases (15 awards, $369 thousand combined potential value), the National Institute on Drug Abuse (9 awards, $329 thousand), and the National Institute of Environmental Health Sciences (10 awards, $294 thousand) leading. The Office of the Director (14 awards, $114 thousand) and Veterans Health Administration entities round out the active set. Work flows through blanket purchase agreements under NIH procurement vehicles, including BPA HHSN263200100055127B (6 task orders).
Activity has been sporadic over the past five years — two awards in 2021, one in 2022, two in 2023, one in 2024, and one in 2026 — reflecting the episodic, small-dollar nature of research animal procurement. The combined potential value across all 92 awards in the source data is $2 million, though obligated dollars total $8.6 million, indicating that invoicing and payment occur substantially over time and across multiple contract periods. Only one award reaches ultimate completion inside the next twenty-four months ($22 thousand potential value), presenting minimal near-term recompete pressure. Work is categorized primarily under NAICS Research and Development in Biotechnology (30 awards) and PSC Reference Laboratory Testing (33 awards), with secondary activity in live animals and medical supplies.
Quick answers
What is Ingenious Targeting Laboratory Inc.'s UEI?
Ingenious Targeting Laboratory Inc.'s Unique Entity ID (UEI) in SAM.gov is KLFLHV967JW4.
What is Ingenious Targeting Laboratory Inc.'s CAGE code?
Ingenious Targeting Laboratory Inc.'s CAGE code is 3DC70.
What is Ingenious Targeting Laboratory Inc.'s primary NAICS code?
Ingenious Targeting Laboratory Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Ingenious Targeting Laboratory Inc. located?
Ingenious Targeting Laboratory Inc.'s physical address in SAM.gov is 761 Coates Ave #80, Holbrook, NY 11741, USA.
Is Ingenious Targeting Laboratory Inc. registered in SAM.gov?
Yes. Ingenious Targeting Laboratory Inc.'s SAM.gov registration is active through March 9, 2027.
What is Ingenious Targeting Laboratory Inc.'s most recent federal award?
Ingenious Targeting Laboratory Inc.'s most recent federal contract award is Niddk: supplies - this firm fixed price purchase order is awarded for custom conditional knockin mouse to ingenious… (75N98026P00016), from Office of Logisitics and Acquisition Operations, on February 20, 2026.
On GovTribe
See Ingenious Targeting Laboratory Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors